Bahr, A.R. et al. 2025. Efficacy and Safety of Tislelizumab in Combination with Chemotherapy versus Placebo Plus Chemotherapy in Patients with Advanced Gastric Cancer or Gastroesophageal Junction Cancer: A Systematic Review of Randomized Controlled Trials. ASIDE Gastroenterology. 1, 2 (Jun. 2025), 16–20. DOI:https://doi.org/10.71079/ASIDE.GI.06052577.